Fosun-BioNTech COVID-19 vaccine completes China regulator review - media

Chinese regulators have completed an expert review of a COVID-19 mRNA vaccine developed by Germany's BioNTech and Fosun Pharma and the shot is in the administration review stage, Caixin reported, citing the Chinese company. China hasn't approved any COVID-19 vaccine developed overseas but greenlighted several domestic brands, administering 1.4 billion doses so far, or two-fifths of the global total of 3.47 billion doses